
Immunex Pharmaceuticals Private Limited
About Immunex Pharmaceuticals Private Limited
Data last updated:
Immunex Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 June 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51392MH1994PTC078973. Its GSTIN is 27AAACI1095E1ZT (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹93.78 Lakh. It is led by directors including Shivam Rajiv Bohra and Ashutosh Rajiv Bohra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 74/80 Babu Genu Roadsouri Bldg 3rd Floor Kalbadevi Road, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.77 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹3.38 Lakh (net margin 26.5%) and EBITDA of ₹4.4 Lakh (EBITDA margin 34.4%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 2% over five years.
Court records list 6 cases involving the company, including 6 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Immunex Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address74/80 Babu Genu Roadsouri Bldg 3rd Floor Kalbadevi Road, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Immunex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Immunex Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Immunex Pharmaceuticals Private Limited, buy the company report.
Financials of Immunex Pharmaceuticals Private Limited
FY 2025 filings availableImmunex Pharmaceuticals Private Limited reported revenue of ₹12.77 Lakh (down 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 38% fall in the latest year. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 34.4% | ||||
| Net Profit Margin | 26.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Immunex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Immunex Pharmaceuticals Private Limited
Immunex Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivam Rajiv Bohra Also directs: Julie (India) Ltd, Bijul Pharmachem Private Limited, Alliance Soaps Private Limited and 5 more | Director | 14 Feb 2020 | 6 Years 8 Months | Current |
| Ashutosh Rajiv Bohra Also directs: Julie (India) Ltd, Bijul Pharmachem Private Limited, Caplin Viniyog Pvt.Ltd. and 2 more | Director | 10 Feb 2023 | 3 Years 8 Months | Current |
| Rajiv Bijayshankar Bohra Also directs: Julie (India) Ltd, Bijul Pharmachem Private Limited, Alliance Soaps Private Limited and 5 more | Director | 02 Sep 2013 | 13 Years 2 Months | Current |
Auditor
Immunex Pharmaceuticals Private Limited is audited by SHANKARLAL JAIN & ASSOCIATES LLP for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHANKARLAL JAIN & ASSOCIATES LLP | FY 2018 | 109901W |
Shareholding
The shareholding of Immunex Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Immunex Pharmaceuticals Private Limited, buy the company report.
Legal cases
Immunex Pharmaceuticals Private Limited has 6 court cases on record: 6 filed by Immunex Pharmaceuticals. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 0 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CHS) | Filed by the company against Elder Healthcare Limited and Torrent Pharmaceuticals Ltd. (Applicant/Intervener) and 1 other | Pending |
| Bombay High Court | Company petition | Filed by the company against Elder Health Care Limited Cin No. L24230mh1988plc046613 | Disposed |
| Bombay High Court | Court case (CONP) | Filed by the company against Elder Healthcare Limited and 5 Ors | Disposed |
| Bombay High Court | Company petition | Filed by the company against Maverick Productions Private Limited (Cin U92100mh2005ptc151262) | Disposed |
| Bombay High Court | Arbitration matter | Filed by the company against Elder Healthcare Limited | Disposed |
To see the full case history of Immunex Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immunex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Immunex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACI1095E1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Immunex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Immunex Pharmaceuticals Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Ashutosh Rajiv Bohra ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Immunex Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 June 1994 (32+ years old) and is registered under CIN U51392MH1994PTC078973.
Immunex Pharmaceuticals has 3 current directors:
- Shivam Rajiv Bohra - Director
- Ashutosh Rajiv Bohra - Director
- Rajiv Bijayshankar Bohra - Director
The latest financial statements of Immunex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Immunex Pharmaceuticals is 27AAACI1095E1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Immunex Pharmaceuticals is U51392MH1994PTC078973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immunex Pharmaceuticals has 6 court cases on record: 6 filed by the company. 1 is pending.
Immunex Pharmaceuticals was incorporated on 14 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
Ashutosh Rajiv Bohra ceased to be Additional Director on 29 Sep 2023. Ashutosh Rajiv Bohra was appointed as Director on 10 Feb 2023. Chandrashekhar Bijayshankar Bohra ceased to be Director on 10 Mar 2021. Immunex Pharmaceuticals has 9 board changes on record in total.
The registered office of Immunex Pharmaceuticals is at 7480 Babu Genu Roadsouri Bldg 3rd Floor Kalbadevi Road, Mumbai, Maharashtra, India – 400002.
Immunex Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

